Tangen Biosciences lands $9 mln Series A
Branford, Connecticut-based Tangen Biosciences Inc, a molecular diagnostics company, has raised $9 million in Series A funding. Connecticut Innovations led the round with participation from other investors that included VC23, Axiom and Leading Edge Ventures.
20 June 2019•1 min read
